vs
ABERCROMBIE & FITCH CO（ANF）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是ABERCROMBIE & FITCH CO的1.1倍（$1.4B vs $1.3B），瑞思迈净利率更高（27.6% vs 8.8%，领先18.8%），瑞思迈同比增速更快（11.0% vs 6.8%），瑞思迈自由现金流更多（$311.2M vs $131.8M），过去两年瑞思迈的营收复合增速更高（9.0% vs -5.8%）
A&F（阿伯克龙比与菲奇）是1892年成立的美国生活方式零售品牌，主打面向20岁出头至45岁左右客群的潮流服饰，总部位于俄亥俄州新奥尔巴尼。旗下运营Abercrombie Kids、Your Personal Best、霍利斯特（Hollister Co.）、Gilly Hicks四个子品牌，全品牌直营门店超780家。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
ANF vs RMD — 直观对比
营收规模更大
RMD
是对方的1.1倍
$1.3B
营收增速更快
RMD
高出4.2%
6.8%
净利率更高
RMD
高出18.8%
8.8%
自由现金流更多
RMD
多$179.4M
$131.8M
两年增速更快
RMD
近两年复合增速
-5.8%
损益表 — Q3 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $1.4B |
| 净利润 | $113.0M | $392.6M |
| 毛利率 | 62.5% | 61.8% |
| 营业利润率 | 12.0% | 34.6% |
| 净利率 | 8.8% | 27.6% |
| 营收同比 | 6.8% | 11.0% |
| 净利润同比 | -14.4% | 13.9% |
| 每股收益（稀释后） | $2.36 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANFRMD
| Q4 25 | $1.3B | $1.4B | ||
| Q3 25 | $1.2B | $1.3B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.2B | $1.3B | ||
| Q3 24 | $1.1B | $1.2B | ||
| Q2 24 | $1.0B | $1.2B | ||
| Q1 24 | $1.5B | $1.2B |
净利润ANFRMD
| Q4 25 | $113.0M | $392.6M | ||
| Q3 25 | $141.4M | $348.5M | ||
| Q2 25 | $80.4M | $379.7M | ||
| Q1 25 | $187.2M | $365.0M | ||
| Q4 24 | $132.0M | $344.6M | ||
| Q3 24 | $133.2M | $311.4M | ||
| Q2 24 | $113.8M | $292.2M | ||
| Q1 24 | $158.4M | $300.5M |
毛利率ANFRMD
| Q4 25 | 62.5% | 61.8% | ||
| Q3 25 | 62.6% | 61.5% | ||
| Q2 25 | 62.0% | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | 65.1% | 58.6% | ||
| Q3 24 | 64.9% | 58.6% | ||
| Q2 24 | 66.4% | 58.5% | ||
| Q1 24 | 62.9% | 57.9% |
营业利润率ANFRMD
| Q4 25 | 12.0% | 34.6% | ||
| Q3 25 | 17.1% | 33.4% | ||
| Q2 25 | 9.3% | 33.7% | ||
| Q1 25 | 16.2% | 33.0% | ||
| Q4 24 | 14.8% | 32.5% | ||
| Q3 24 | 15.5% | 31.6% | ||
| Q2 24 | 12.7% | 31.2% | ||
| Q1 24 | 15.3% | 31.3% |
净利率ANFRMD
| Q4 25 | 8.8% | 27.6% | ||
| Q3 25 | 11.7% | 26.1% | ||
| Q2 25 | 7.3% | 28.2% | ||
| Q1 25 | 11.8% | 28.3% | ||
| Q4 24 | 10.9% | 26.9% | ||
| Q3 24 | 11.7% | 25.4% | ||
| Q2 24 | 11.2% | 23.9% | ||
| Q1 24 | 10.9% | 25.1% |
每股收益（稀释后）ANFRMD
| Q4 25 | $2.36 | $2.68 | ||
| Q3 25 | $2.91 | $2.37 | ||
| Q2 25 | $1.59 | $2.58 | ||
| Q1 25 | $3.55 | $2.48 | ||
| Q4 24 | $2.50 | $2.34 | ||
| Q3 24 | $2.50 | $2.11 | ||
| Q2 24 | $2.14 | $1.97 | ||
| Q1 24 | $2.97 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $631.0M | $1.4B |
| 总债务越低越好 | — | $403.9M |
| 股东权益账面价值 | $1.3B | $6.3B |
| 总资产 | $3.5B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资ANFRMD
| Q4 25 | $631.0M | $1.4B | ||
| Q3 25 | $603.5M | $1.4B | ||
| Q2 25 | $607.6M | $1.2B | ||
| Q1 25 | $888.9M | $932.7M | ||
| Q4 24 | $738.9M | $521.9M | ||
| Q3 24 | $738.4M | $426.4M | ||
| Q2 24 | $864.2M | $238.4M | ||
| Q1 24 | $900.9M | $237.9M |
总债务ANFRMD
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益ANFRMD
| Q4 25 | $1.3B | $6.3B | ||
| Q3 25 | $1.3B | $6.1B | ||
| Q2 25 | $1.2B | $6.0B | ||
| Q1 25 | $1.3B | $5.5B | ||
| Q4 24 | $1.2B | $5.3B | ||
| Q3 24 | $1.2B | $5.2B | ||
| Q2 24 | $1.1B | $4.9B | ||
| Q1 24 | $1.0B | $4.6B |
总资产ANFRMD
| Q4 25 | $3.5B | $8.5B | ||
| Q3 25 | $3.3B | $8.3B | ||
| Q2 25 | $3.1B | $8.2B | ||
| Q1 25 | $3.3B | $7.6B | ||
| Q4 24 | $3.3B | $7.1B | ||
| Q3 24 | $3.0B | $7.2B | ||
| Q2 24 | $3.0B | $6.9B | ||
| Q1 24 | $3.0B | $6.8B |
负债/权益比ANFRMD
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $200.1M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $131.8M | $311.2M |
| 自由现金流率自由现金流/营收 | 10.2% | 21.9% |
| 资本支出强度资本支出/营收 | 5.3% | 2.0% |
| 现金转化率经营现金流/净利润 | 1.77× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $384.5M | $1.8B |
8季度趋势，按日历期对齐
经营现金流ANFRMD
| Q4 25 | $200.1M | $339.7M | ||
| Q3 25 | $116.9M | $457.3M | ||
| Q2 25 | $-4.0M | $538.8M | ||
| Q1 25 | $307.6M | $578.7M | ||
| Q4 24 | $142.6M | $308.6M | ||
| Q3 24 | $165.1M | $325.5M | ||
| Q2 24 | $95.0M | $440.1M | ||
| Q1 24 | $303.3M | $402.0M |
自由现金流ANFRMD
| Q4 25 | $131.8M | $311.2M | ||
| Q3 25 | $50.7M | $414.4M | ||
| Q2 25 | $-54.8M | $508.2M | ||
| Q1 25 | $256.8M | $557.9M | ||
| Q4 24 | $92.2M | $288.0M | ||
| Q3 24 | $122.3M | $307.7M | ||
| Q2 24 | $56.1M | $415.2M | ||
| Q1 24 | $274.1M | $380.8M |
自由现金流率ANFRMD
| Q4 25 | 10.2% | 21.9% | ||
| Q3 25 | 4.2% | 31.0% | ||
| Q2 25 | -5.0% | 37.7% | ||
| Q1 25 | 16.2% | 43.2% | ||
| Q4 24 | 7.6% | 22.5% | ||
| Q3 24 | 10.8% | 25.1% | ||
| Q2 24 | 5.5% | 33.9% | ||
| Q1 24 | 18.9% | 31.8% |
资本支出强度ANFRMD
| Q4 25 | 5.3% | 2.0% | ||
| Q3 25 | 5.5% | 3.2% | ||
| Q2 25 | 4.6% | 2.3% | ||
| Q1 25 | 3.2% | 1.6% | ||
| Q4 24 | 4.2% | 1.6% | ||
| Q3 24 | 3.8% | 1.5% | ||
| Q2 24 | 3.8% | 2.0% | ||
| Q1 24 | 2.0% | 1.8% |
现金转化率ANFRMD
| Q4 25 | 1.77× | 0.87× | ||
| Q3 25 | 0.83× | 1.31× | ||
| Q2 25 | -0.05× | 1.42× | ||
| Q1 25 | 1.64× | 1.59× | ||
| Q4 24 | 1.08× | 0.90× | ||
| Q3 24 | 1.24× | 1.05× | ||
| Q2 24 | 0.83× | 1.51× | ||
| Q1 24 | 1.91× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANF
| Hollister | $673.3M | 52% |
| Abercrombie | $617.3M | 48% |
| Gift Card | $25.7M | 2% |
| Royalty | $19.5M | 2% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
